- €500 million share repurchase program to launch in Q1 2026.
- Animal Nutrition & Health classified as Assets Held for Sale.
- Stable dividend of €2.50 per share maintained.
- Investor Event scheduled for March 12, 2026.
Financial Performance
DSM-Firmenich reported strong financial results for 2025, driven by synergies and strategic initiatives. A new €500 million share repurchase program is set to launch in Q1 2026, and the company will maintain a stable dividend of €2.50 per share.
Strategic Developments
The divestment of Animal Nutrition & Health has been announced, marking the completion of DSM-Firmenich's strategic plan. This division is now classified as Assets Held for Sale and Discontinued Operations.
Sustainability Achievements
Significant progress was made in sustainability, with DSM-Firmenich receiving EcoVadis Platinum and CDP double A ratings for Climate & Water.
Future Outlook
With the strategic plan executed, DSM-Firmenich is poised for its next phase as a consumer-focused company. An Investor Event is scheduled for March 12, 2026, to discuss future directions.
